News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Mynet Finans Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
PetMed Express reported a wider-than-expected loss and significantly missed revenue forecasts for its fiscal first quarter of 2027. Despite a 19.9% year-over-year revenue decline, the company highlighted sales stabilization above $40 million for the third consecutive quarter and a substantial narrowing of its net …
PetMed Express (PETS) reported a challenging first quarter of fiscal 2027 with a 19.9% revenue decrease, widened operating loss, and a net loss, causing its stock to fall 6.4%. Insider trading activity shows one purchase of 25,000 shares, while hedge funds largely decreased their …
PetMed Express (PETS) has granted its Interim CEO and President, Leslie C.G. Campbell, 60,000 restricted shares of common stock. This award, made under the 2024 Omnibus Incentive Plan, vests fully on the first anniversary of the grant date, subject to continued employment and specific …
This article is a placeholder for an earnings snapshot for PetMed. It indicates that fiscal Q1 earnings information is expected, but the content itself is currently empty.
* PetMed Express press release [https://seekingalpha.com/pr/20619131-petmeds-announces-first-quarter-financial-results] (PETS [https://seekingalpha.com/symbol/PETS]): Q1 GAAP EPS of -$0.28 misses by $0.40. * Revenue of $41.02M (-19.9% Y/Y). MORE ON PETMED EXPRESS * PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript [https://seekingalpha.com/article/4911174-petmed-express-inc-pets-q4-2026-earnings-call-prepared-remarks-transcript] * PetMed Express: High-Risk Turnaround, …
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported a 5.29% beneficial ownership stake in PetMed Express (PETS), totaling 1,131,230 shares of common stock as of June 30, 2026. This updated filing, a Schedule 13G/A, indicates that the entities hold sole voting and …
PetMed Express (PETS) director Peter Batushansky was granted 55,555 restricted shares of common stock under the company's 2024 Omnibus Incentive Plan. These shares will fully vest on August 11, 2027, provided he continues his service on the Board of Directors, bringing his total direct …
PetMed Express (PETS) has awarded director Justin L. Mennen a restricted stock grant of 55,555 shares of common stock under the company's 2024 Omnibus Incentive Plan. These shares will fully vest on August 11, 2027, provided Mennen continues his service on the Board of …
PetMed Express, Inc. is projected to report earnings of 12 cents per share. This information is presented as an earnings preview from Reuters, indicating an upcoming financial announcement for the company.
PetMed Express (NASDAQ: PETS), an online pet pharmacy, is experiencing significant losses and declining sales, leading to its stock trading at a deep discount of around $1.96 per share. Despite the low valuation and a recent unsolicited acquisition proposal of $3.00 per share, the …
This article provides an earnings forecast for Petmed Express Inc (PETS), detailing its current earnings forecast score, average price target, and analyst rating. It highlights that the company ranks 19th out of 29 in its industry with a "Sell" rating from one analyst, and …
This Yahoo Finance page provides a comprehensive overview of PetMed Express, Inc. (PETS) stock, including its current price, historical data, financial performance, and analyst insights. The company operates as a pet pharmacy in the United States, offering a range of prescription and non-prescription pet …
PetMed Express, Inc. (PETS) is expected to release its Q1'26 earnings on August 13, after market close, with an estimated revenue of $71.00 million and EPS of $0.12. The article provides a detailed table comparing historical reported and estimated revenue and EPS figures from …
This article provides detailed financial data and company information for PetMed Express Inc (NASDAQ: PETS), including its stock performance, fundamentals, and recent financial results. It highlights a partnership with Dutch for accessible telehealth services for pets and offers a comprehensive overview of the company's …
PetMed Express, Inc. (Nasdaq: PETS) announced that it will report its financial results for the first quarter of fiscal year 2027, which ended June 30, 2026, on Thursday, August 13, 2026, after the market closes. The company will also host a conference call and …
PetMed Express will report its first-quarter fiscal year 2027 financial results on August 13, 2026, after the market closes. The online pet pharmacy will host a conference call and webcast at 4:30 PM Eastern Time to discuss these results. A replay of the call …
PetMed Express (NASDAQ: PETS) announced it will release its financial results for the first quarter of fiscal year 2027, covering the period ended June 30, 2026,
This article analyzes the institutional confidence in Petmed Express Inc (PETS), showing its current institutional shareholding score and ranking within the Food & Drug Retailing industry. It details the latest institutional shareholding proportion, the largest institutional shareholder (James Simons), and a list of key …
PetMed Express, Inc. (LSX:121843) generated €154.95 million in revenue last year, with its Reorder segment contributing the most at €127.91 million. The United States was the primary regional contributor, accounting for all reported revenue. This indicates a focus on the U.S. market and recurring …
This article provides a historical overview of Petmed Express Inc (PETS) dividends and stock splits. It details cash dividend payouts from May 2021 to August 2023, specifying the dividend amount, record date, payment date, and ex-dividend date for each. The data indicates that PETS …
This article provides a revenue breakdown for Petmed Express Inc (PETS), focusing on its business segments. Key revenue contributions for FY2026Q3 show that reorder sales account for the vast majority (83.67%) of revenue, followed by new order sales (12.37%), and membership fees (3.96%). Regional …
Petmed Express Inc (PETS) closed at $1.99, down 2.93% on July 24, 2026. The company, a direct-to-consumer pet pharmacy, shows strong fundamentals and high growth potential but is considered fairly valued with analysts rating it as "Sell." Its stock price is expected to trend …
PetMed Express (NASDAQ: PETS) has awarded interim CFO Douglas Krulik 32,500 restricted common shares and 32,500 performance share units (PSUs). The restricted shares vest 50% on June 26, 2027, and 50% on June 26, 2028, contingent on continued employment. The PSUs are tied to …
PetMed Express, Inc. (PETS) stock closed at $1.99, down 2.93% on July 24, 2026, with an after-hours price of $1.9013. The company, a pet pharmacy providing prescription and non-prescription medications and supplies, has seen significant negative returns over the past year and five years, …
PetMed Express is selling its Delray Beach headquarters for $37 million in a sale-leaseback agreement with Redfearn Capital Acquisitions. The deal involves leasing back the 100,519-square-foot property for an initial 10-year term, with options for extension. This move aims to monetize real estate assets …
Search by ticker symbol or company name and select a result to open its chart.